Erlotinib Tablets I.p. 100 Mg

Get a Price/Quote

MOQ : 10 Boxes

Erlotinib Tablets I.p. 100 Mg Specification

Dosage Form
Tablet

Indication
Non-small cell lung cancer, pancreatic cancer, other types of cancer as prescribed

Salt Composition
Erlotinib 100 mg

Feature
Prescription drug, anticancer, oral tablet

Application
Oral anticancer therapy

Physical Color/Texture
Tablet form, white to off-white

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24 months

Side Effects
Rash, diarrhea, loss of appetite, fatigue

Prescription/Non Prescription
Prescription

Pack Size
30 Tablets per box

Usage
As directed by oncologist

Caution
To be sold by retail on the prescription of an oncologist only

Route of Administration
Oral

Packaging Type
Box

Patient Category
Adults

Marketed By
Mylan Pharmaceuticals

Strength
100 mg per tablet

Brand Name
ERLOTERO-100

Regulatory Status
IP (Indian Pharmacopoeia)

Drug Class
Tyrosine Kinase Inhibitor

Erlotinib Tablets I.p. 100 Mg Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Erlotinib Tablets I.p. 100 Mg About

Experience imposing efficacy with ERLOTERO-100 (Erlotinib Tablets I.P. 100 mg), a lustrous choice for oral anticancer therapy. Specially formulated by Mylan Pharmaceuticals, these ace tablets are trusted for the treatment of non-small cell lung cancer, pancreatic cancer, and other conditions as prescribed. Each pack contains 30 tablets, designed for adult use under oncologist guidance. Get It Now-Pick Yours and Personalise your cancer management with confidence. ERLOTERO-100 is a prescription-only medicine, featuring superior quality, safety, and a 24-month shelf life. Store securely below 30C, away from light and moisture.

Targeted Cancer Therapy With Erlotinib Tablets I.P. 100 mg

Erlotinib Tablets I.P. 100 mg, marketed as ERLOTERO-100, are suitable for adult patients requiring targeted therapy for cancers such as non-small cell lung cancer and pancreatic cancer. This prescription medication harnesses the power of tyrosine kinase inhibition and is administered orally, ensuring patient convenience. Special features include strict adherence to Indian Pharmacopoeia standards, high pharmaceutical quality, and ease of storage, making it an ideal application for intensive cancer care as directed by an oncologist.

Comprehensive Packaging and Supply Details for Erlotinib Tablets

ERLOTERO-100 comes securely packed in boxes containing 30 tablets each, ensuring integrity and protection from moisture and light. We supply directly from India, with flexible payment terms to suit your requirements. The FOB Port is available for prompt distribution, and you may request a quotation or inquire about the asking price for bulk orders. Our responsive service ensures that all shipment and delivery arrangements for Erlotinib Tablets I.P. 100 mg align with your needs.

FAQ's of Erlotinib Tablets I.p. 100 Mg:

Q: How should ERLOTERO-100 (Erlotinib Tablets I.P. 100 mg) be taken?

A: ERLOTERO-100 tablets should be taken orally, strictly as directed by your oncologist. It is essential to follow the prescribed dosage and schedule for optimal effectiveness.

Q: What conditions are treated with Erlotinib Tablets I.P. 100 mg?

A: Erlotinib Tablets are indicated for the treatment of non-small cell lung cancer, pancreatic cancer, and may be used for other cancers upon your oncologist's recommendation.

Q: When should I consult my oncologist about starting ERLOTERO-100?

A: Consult your oncologist promptly if you have been diagnosed with cancers appropriate for Erlotinib therapy. Only they can determine if this medication is right for your condition.

Q: Where should ERLOTERO-100 be stored for best results?

A: Store ERLOTERO-100 below 30C, in a dry place protected from light and moisture, to maintain its efficacy throughout its 24-month shelf life.

Q: What are the possible side effects of using Erlotinib Tablets?

A: Common side effects include rash, diarrhea, loss of appetite, and fatigue. Speak with your oncologist about any side effects or health concerns you observe during treatment.

Q: How can I get a quotation or inquire about the supply of ERLOTERO-100?

A: You can request a quotation or supply information by contacting our distribution team directly. We offer flexible payment terms and will provide asking prices and further details upon inquiry.

Tell us about your requirement